These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30415925)

  • 1. Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP Production.
    Knudsen JG; Hamilton A; Ramracheya R; Tarasov AI; Brereton M; Haythorne E; Chibalina MV; Spégel P; Mulder H; Zhang Q; Ashcroft FM; Adam J; Rorsman P
    Cell Metab; 2019 Feb; 29(2):430-442.e4. PubMed ID: 30415925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of KATP channels in glucose-regulated glucagon secretion and impaired counterregulation in type 2 diabetes.
    Zhang Q; Ramracheya R; Lahmann C; Tarasov A; Bengtsson M; Braha O; Braun M; Brereton M; Collins S; Galvanovskis J; Gonzalez A; Groschner LN; Rorsman NJ; Salehi A; Travers ME; Walker JN; Gloyn AL; Gribble F; Johnson PR; Reimann F; Ashcroft FM; Rorsman P
    Cell Metab; 2013 Dec; 18(6):871-82. PubMed ID: 24315372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-cell uncoupling protein 2 regulates reactive oxygen species production, which influences both insulin and glucagon secretion.
    Robson-Doucette CA; Sultan S; Allister EM; Wikstrom JD; Koshkin V; Bhattacharjee A; Prentice KJ; Sereda SB; Shirihai OS; Wheeler MB
    Diabetes; 2011 Nov; 60(11):2710-9. PubMed ID: 21984579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of glucagon secretion at low glucose concentrations: evidence for adenosine triphosphate-sensitive potassium channel involvement.
    Muñoz A; Hu M; Hussain K; Bryan J; Aguilar-Bryan L; Rajan AS
    Endocrinology; 2005 Dec; 146(12):5514-21. PubMed ID: 16123162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and Molecular Adaptations of Enteroendocrine L-Cells in Male Obese Mice Are Associated With Preservation of Pancreatic α-Cell Function and Prevention of Hyperglycemia.
    Dusaulcy R; Handgraaf S; Skarupelova S; Visentin F; Vesin C; Heddad-Masson M; Reimann F; Gribble F; Philippe J; Gosmain Y
    Endocrinology; 2016 Oct; 157(10):3832-3843. PubMed ID: 27547850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Submembrane ATP and Ca2+ kinetics in α-cells: unexpected signaling for glucagon secretion.
    Li J; Yu Q; Ahooghalandari P; Gribble FM; Reimann F; Tengholm A; Gylfe E
    FASEB J; 2015 Aug; 29(8):3379-88. PubMed ID: 25911612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fumarate Hydratase Deletion in Pancreatic β Cells Leads to Progressive Diabetes.
    Adam J; Ramracheya R; Chibalina MV; Ternette N; Hamilton A; Tarasov AI; Zhang Q; Rebelato E; Rorsman NJG; Martín-Del-Río R; Lewis A; Özkan G; Do HW; Spégel P; Saitoh K; Kato K; Igarashi K; Kessler BM; Pugh CW; Tamarit-Rodriguez J; Mulder H; Clark A; Frizzell N; Soga T; Ashcroft FM; Silver A; Pollard PJ; Rorsman P
    Cell Rep; 2017 Sep; 20(13):3135-3148. PubMed ID: 28954230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A K ATP channel-dependent pathway within alpha cells regulates glucagon release from both rodent and human islets of Langerhans.
    MacDonald PE; De Marinis YZ; Ramracheya R; Salehi A; Ma X; Johnson PR; Cox R; Eliasson L; Rorsman P
    PLoS Biol; 2007 Jun; 5(6):e143. PubMed ID: 17503968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
    Cryer PE
    Endocrinology; 2012 Mar; 153(3):1039-48. PubMed ID: 22166985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin regulates islet alpha-cell function by reducing KATP channel sensitivity to adenosine 5'-triphosphate inhibition.
    Leung YM; Ahmed I; Sheu L; Gao X; Hara M; Tsushima RG; Diamant NE; Gaisano HY
    Endocrinology; 2006 May; 147(5):2155-62. PubMed ID: 16455778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon secretion from pancreatic α-cells.
    Briant L; Salehi A; Vergari E; Zhang Q; Rorsman P
    Ups J Med Sci; 2016 May; 121(2):113-9. PubMed ID: 27044683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Resistance is futile?' - paradoxical inhibitory effects of K
    Zhang Q; Dou H; Rorsman P
    J Physiol; 2020 Nov; 598(21):4765-4780. PubMed ID: 32716554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of dysregulated glucagon secretion in type 2 diabetes.
    D'Alessio D
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():126-32. PubMed ID: 21824266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
    Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
    Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagonotropic and Glucagonostatic Effects of KATP Channel Closure and Potassium Depolarization.
    Früh E; Elgert C; Eggert F; Scherneck S; Rustenbeck I
    Endocrinology; 2021 Jan; 162(1):. PubMed ID: 32790843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic activation of α-cell glucokinase in mice causes enhanced glucose-suppression of glucagon secretion during normal and diabetic states.
    Bahl V; Lee May C; Perez A; Glaser B; Kaestner KH
    Mol Metab; 2021 Jul; 49():101193. PubMed ID: 33610858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the malate-aspartate shuttle in mouse pancreatic islets abolishes glucagon secretion without affecting insulin secretion.
    Stamenkovic JA; Andersson LE; Adriaenssens AE; Bagge A; Sharoyko VV; Gribble F; Reimann F; Wollheim CB; Mulder H; Spégel P
    Biochem J; 2015 May; 468(1):49-63. PubMed ID: 25731850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
    Whalley NM; Pritchard LE; Smith DM; White A
    J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.